Is there a valid hypofractionated regimen for postop cervical/endometrial cancers given COVID-19?

There are no good prospective series of hypofractionation for cervix and endometrial cancer in the curative setting.

Agree there are no prospective series, that would guide hypofractionation in genycological cancers, esp in the post op setting. However, there are enough data in other sites, that hypofractionated RT works well for microscopic disease and in adjuvant settings, breast cancer regimens (42.5/16 or 40/1...